Jaimee Hackett
About Jaimee Hackett
Jaimee Hackett is a Diabetes Sales Specialist at Bristol-Myers Squibb in New Jersey, with over a decade of experience in the field and a background in Clinical Psychology.
Current Role at Bristol-myers Squibb
Jaimee Hackett currently serves as a Diabetes Sales Specialist at Bristol-myers Squibb in New Jersey, United States. In this role, Jaimee utilizes their extensive experience in clinical sales to support the company’s initiatives in the diabetes sector. With a career spanning over a decade in this specialized field, Jaimee contributes to advancing diabetes care through effective sales strategies and a deep understanding of patient needs.
Previous Experience at Thermo Fisher Scientific
From 2009 to 2012, Jaimee Hackett worked as a Clinical Sales Specialist at Thermo Fisher Scientific in Waltham, Massachusetts. During these three years, Jaimee gained valuable experience in clinical sales, which broadened their expertise and strengthened their ability to meet the needs of healthcare providers and patients alike.
Educational Background in Clinical Psychology
Jaimee Hackett pursued their undergraduate studies at Eastern Connecticut State University, where they earned a Bachelor's degree in Clinical Psychology from 1997 to 2001. This educational background has provided Jaimee with a solid foundation in understanding human behavior and patient care, which is particularly beneficial in their current role in the diabetes sector.
Extensive Experience in Clinical Sales
Jaimee Hackett has amassed over 14 years of experience in clinical sales. Starting their career in the healthcare industry in the early 2000s, Jaimee has developed a deep expertise in this field. Their extensive background has equipped them with the skills necessary to successfully navigate and contribute to the rapidly evolving healthcare landscape.
Transition from Massachusetts to New Jersey
After spending several years working in Waltham, Massachusetts, Jaimee Hackett moved to New Jersey to take on their current role at Bristol-myers Squibb. This transition marks a significant step in their career, allowing them to continue their professional growth while contributing to advancements in diabetes treatment and care.